AMAG
AMAG Pharmaceuticals
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
170 hedge funds and large institutions have $408M invested in AMAG Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 60
22% less capital invested
Capital invested by funds: $523M → $408M (-$115M)
Holders
170
Holding in Top 10
1
Calls
$13.5M
Puts
$7.61M
Top Buyers
| 1 | +$6.91M | |
| 2 | +$4.84M | |
| 3 | +$3.56M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$3.5M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.37M |
Top Sellers
| 1 | -$9.89M | |
| 2 | -$3.31M | |
| 3 | -$2.6M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.47M |
| 5 |
Man Group
London,
United Kingdom
|
-$2.31M |